

Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus.
You can purchase shares of VAXART INC by Vaxart, Inc. (OTCQX:VXRT) through any online brokerage.
There are no as such competitors for VAXART INC by Vaxart, Inc..
VAXART INC by Vaxart, Inc. has a consensus price target of $3.00.
The stock price for VAXART INC by Vaxart, Inc. (OTCQX: VXRT) is $0.3258 last updated November 20, 2026 at 12:57 PM EST.
There are no upcoming dividends for VAXART INC by Vaxart, Inc..
VAXART INC by Vaxart, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for VAXART INC by Vaxart, Inc..
VAXART INC by Vaxart, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under...